In-Licensing Lessons: Benchmarking Best Practice

On Demand Webinar

In-Licensing Lessons: Benchmarking Best Practice

For Big Pharma companies, biotechs present a world of potential opportunities to boost pipelines with reduced risk.

Watch now

I would like to receive Evaluate industry & market reports, and the latest news from Evaluate. エバリュエートの業界・市場レポートやイベント等最新ニュースを受け取る（無料）

Connect with our advisory team
Get insights on BD&L, portfolio, and competitive intelligence 業界特化型コンサルタントとの個別相談を希望する
BD&L／ポートフォリオ／競合インテリジェンスについて、担当者よりご連絡いたします

Your information will be used in accordance with our Privacy notice. ご提供いただいた情報は、当社のプライバシー通知に基づき適切に取り扱います。

About this webinar

However, it’s a very large ecosystem, which makes it difficult to identify, screen and select the assets that fit your strategy. Biotechs have big dreams and finding mutually acceptable common ground is key to a successful partnership.

In this short webinar, our experts will discuss some of the ways in which you can strike a deal that will enhance your pipeline.

We’ll consider:

How to take a focused but flexible approach to deal structure
Effective ways to benchmark deals
Trends in deal structures, including upfront payments and royalties

Speakers

Ben Folwell

Senior Associate, Consulting & Analytics, Evaluate

Pengfei Lu

Senior Consultant, Evaluate

Core Forecasting Products

Regional Forecasts

Forecast Enablement

Bespoke Forecasting

Portfolio & Scenario Analysis

Competitive Context

Pipeline & Asset Intelligence

Deal and Asset Evaluation

Bespoke Business Development Analysis

Scientific & Pipeline Intelligence

Competitive Intelligence Platforms

Epidemiology Context

Market and Company Benchmarks

Custom Solutions

Support

Training and Enablement

Need Help?

Forecasting

Business Development & Licensing

Portfolio Strategy

Competitive Intelligence

Discover Resources

On Demand Webinar